Oleoylcarnitine, a metabolite that accumulates following suppression of fatty acid β-oxidation, has been shown to promote hepatocarcinogenesis through STAT3 activation in the context of obesity-driven HCC [45]. Here, STAT3 is linked to obesity disorder.